Difference between revisions of "Esophageal stricture"
Jump to navigation
Jump to search
| Line 18: | Line 18: | ||
DDx: | DDx: | ||
*[[GERD]]. | *[[GERD]]. | ||
*[[Barrett's esophagus]]. | |||
*[[Squamous cell carcinoma of the esophagus]]. | *[[Squamous cell carcinoma of the esophagus]]. | ||
*[[Adenocarcinoma of the esophagus]]. | *[[Adenocarcinoma of the esophagus]]. | ||
Revision as of 14:23, 9 January 2014
Esophageal stricture is a clinical diagnosis. Considered broadly, strictures may be benign or malignant.
This article deals primarily with benign stricture of the esophagus or benign esophageal stricture.
General
Treatment:
Microscopic
Features:
- Squamous mucosa:
- +/-Keratinization.
- Intraepithelial lymphocytes.
- Basal cell hyperplasia.
DDx:
- GERD.
- Barrett's esophagus.
- Squamous cell carcinoma of the esophagus.
- Adenocarcinoma of the esophagus.
Sign out
ESOPHAGUS, BIOPSY: - SQUAMOUS MUCOSA WITH BASAL CELL HYPERPLASIA, MILD INTRAEPITHELIAL EDEMA, FOCAL EARLY KERATINIZATION AND INTRAEPITHELIAL LYMPHOCYTES. - SCANT COLUMNAR EPITHELIUM WITH MODERATE CHRONIC INACTIVE INFLAMMATION. - NEGATIVE FOR INTESTINAL METAPLASIA. - NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.
See also
References
- ↑ Hourneaux de Moura, EG.; Toma, K.; Goh, KL.; Romero, R.; Dua, KS.; Felix, VN.; Levine, MS.; Kochhar, R. et al. (Oct 2013). "Stents for benign and malignant esophageal strictures.". Ann N Y Acad Sci 1300: 119-43. doi:10.1111/nyas.12242. PMID 24117639.
- ↑ Singhal, S.; Hasan, SS.; Cohen, DC.; Pfanner, T.; Reznik, S.; Duddempudi, S. (Sep 2013). "Multi-disciplinary approach for management of refractory benign occlusive esophageal strictures.". Therap Adv Gastroenterol 6 (5): 365-70. doi:10.1177/1756283X13492000. PMID 24003337.